Contribution of interferon-γ release assays (IGRAs) to the diagnosis of latent tuberculosis infection after renal transplantation

Transplantation

Volumn 95, Issue 12, 2013, Pages 1485-1490

  Hadaya, Karine ^a   Bridevaux, Pierre Olivier ^a   Roux Lombard, Pascale ^a   Delort, Armelle ^a   Saudan, Patrick ^a   Martin, Pierre Yves ^a   Janssens, Jean Paul ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Interferon release assays; Latent tuberculosis infection; Renal transplantation

Indexed keywords

CYCLOSPORIN A; RAPAMYCIN; TACROLIMUS;

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; KIDNEY TRANSPLANTATION; LATENT TUBERCULOSIS; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY; TUBERCULIN TEST;

ADULT; AGED; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST;

EID: 84880134053     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182907073     Document Type: Article

References (50)

1. Chung WK, Zheng ZL, Sung JY, et al. Validity of interferon-gamma-release assays for the diagnosis of latent tuberculosis in haemodialysis patients. Clin Microbiol Infect 2010; 16: 960.
2. Kazancioglu R, Ozturk S, Gursu M, et al. Tuberculosis in patients on hemodialysis in an endemic region. Hemodial Int 2010; 14: 505.
3. Lee SS, Chou KJ, Dou HY, et al. High prevalence of latent tuberculosis infection in dialysis patients using the interferon-gamma release assay and tuberculin skin test. Clin J Am Soc Nephrol 2010; 5: 1451.
4. Lee SS, Chou KJ, Su IJ, et al. High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test. Infection 2009; 37: 96.
5. Maden E, Bekci TT, Kesli R, et al. Evaluation of performance of Quantiferon assay and tuberculin skin test in end stage renal disease patients receiving hemodialysis. New Microbiol 2011; 34: 351.
6. Petrescu L, Stancu S, Tardei G, et al. Tuberculin skin test, interferon-gamma assay, and T cells subpopulations in hemodialysis patients. J Ren Nutr 2010; 20: S109.
7. Seyhan EC, Sokucu S, Altin S, et al. Comparison ofthe QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients. Transpl Infect Dis 2010; 12: 98.
8. Triverio PA, Bridevaux PO, Roux-Lombard P, et al. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients. Nephrol Dial Transplant 2009; 24: 1952.
9. Simon TA, Paul S, Wartenberg D, et al. Tuberculosis in hemodialysis patients in New Jersey: a statewide study. Infect Control Hosp Epidemiol 1999; 20: 607.
10. Andrew OT, Schoenfeld PY, Hopewell PC, et al. Tuberculosis in patients with end-stage renal disease. Am J Med 1980; 68: 59.
11. Belcon MC, Smith EK, Kahana LM, et al. Tuberculosis in dialysis patients. Clin Nephrol 1982; 17: 14.
12. Lundin AP, Adler AJ, Berlyne GM, et al. Tuberculosis in patients undergoing maintenance hemodialysis. Am J Med 1979; 67: 597.
13. Rutsky EA, Rostand SG. Mycobacteriosis in patients with chronic renal failure. Arch Intern Med 1980; 140: 57.
14. Sasaki S, Akiba T, Suenaga M, et al. Ten years' survey of dialysis-associated tuberculosis. Nephron 1979; 24: 141.
15. Rieder HL. Epidemiologic bais of tuberculosis control. Paris: International Union against Tuberculosis and Lung Diseases; 1999.
16. Kim SH, Lee SO, Park IA, et al. Diagnostic usefulness of a T cell-based assay for latent tuberculosis infection in kidney transplant candidates before transplantation. Transpl Infect Dis 2010; 12: 113.
17. Agarwal SK, Gupta S, Dash SC, et al. Prospective randomised trial of isoniazid prophylaxis in renal transplant recipient. Int Urol Nephrol 2004; 36: 425.
18. Naqvi A, Akhtar F, Naqvi R, et al. Problems of diagnosis and treatment of tuberculosis following renal transplantation. Transplant Proc 1997; 29: 3051.
19. Bumbacea D, Arend SM, Eyuboglu F, et al. The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Eur Respir J 2012; 40: 990.
20. Aguado JM, Herrero JA, Gavalda J, et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA. Transplantation 1997; 63: 1278.
21. Aguado JM, Torre-Cisneros J, Fortun J, et al. Tuberculosis in solidorgan transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis 2009; 48: 1276.
22. Basiri A, Moghaddam SM, Simforoosh N, et al. Preliminary report of a nationwide case-control study for identifying risk factors of tuberculosis following renal transplantation. Transplant Proc 2005; 37: 3041.
23. Batista MV, Pierrotti LC, Abdala E, et al. Endemic and opportunistic infections in Brazilian solid organ transplant recipients. Trop Med Int Health 2011; 16: 1134.
24. Drobniewski FA, Ferguson J. Tuberculosis in renal transplant units. Nephrol Dial Transplant 1996; 11: 768.
25. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solidorgan transplant recipients: impact and implications for management. Clin Infect Dis 1998; 27: 1266.
26. Subramanian A, Dorman S. Mycobacterium tuberculosis in solid organ transplant recipients. Am J Transplant. 2009; 9 Suppl 4: S57.
27. Centers for Disease Control. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infectionV United States, 2010. MMWR 2010; 59: 1.
28. Diel R, Goletti D, Ferrara G, et al. Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 2011; 37:88.
29. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340.
30. Hoffmann M, Tsinalis D, Vernazza P, et al. Assessment of an interferon-gamma release assay for the diagnosis of latent tuberculosis infection in haemodialysis patient. Swiss Med Wkly 2010; 140: 286.
31. Kobashi Y, Mouri K, Obase Y, et al. Clinical evaluationof QuantiFERON TB-2G test for immunocompromised patients. Eur Respir J 2007; 30: 945.
32. Passalent L, Khan K, Richardson R, et al. Detecting latent tuberculosis infection in hemodialysis patients: a head-to-head comparison of the T-SPOT.TB test, tuberculin skin test, and an expert physician panel. Clin J Am Soc Nephrol 2007; 2: 68.
33. Segall L, Covic A. Diagnosis of tuberculosis in dialysis patients: current strategy. Clin J Am Soc Nephrol 2010; 5: 1114.
34. Sester M, Sester U, Clauer P, et al. Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in he-modialysis patients. Kidney Int 2004; 65: 1826.
35. Wauters A, Peetermans WE, Van den Brande P, et al. The value of tuberculin skin testing in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 433.
36. Winthrop KL, Nyendak M, Calvet H, et al. Interferon-gamma release assays for diagnosing Mycobacterium tuberculosis infection in renal dialysis patients. Clin J Am Soc Nephrol 2008; 3: 1357.
37. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159.
38. Diel R, Nienhaus A, Loddenkemper R. Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany. Chest 2007; 131: 1424.
39. Nienhaus A, Schablon A, Costa JT, et al. Systematic review of cost and cost-effectiveness of different TB-screening strategies. BMC Health Serv Res 2011; 11: 247.
40. Kleinert S, Tony HP, Krueger K, et al. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-gamma release assays under real-life conditions. Ann Rheum Dis 2012; 71: 1791.
41. Mancuso JD, Tribble D, Mazurek GH, et al. Impact of targeted testing for latent tuberculosis infection using commercially available diagnostics. Clin Infect Dis 2011; 53: 234.
42. Sarivalasis A, Zellweger J, Faouzi M, et al. Factors associated with latent tuberculosis among asylum seekers in Switzerland: a cross-sectional study in Vaud County. BMC Infect Dis 2012; 12: 285.
43. Vassilopoulos D, Tsikrika S, Hatzara C, et al. Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy. Clin Vaccine Immunol 2011; 18: 2102.
44. Adetifa IM, Ota MO, Walther B, et al. Decay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis cases. PLoS One 2010; 5: e12502.
45. Bosshard V, Roux-Lombard P, Perneger T, et al. Do results of the T-SPOT.TB interferon-gamma release assay change after treatment of tuberculosis? Respir Med 2009; 103: 30.
46. Chee CB, KhinMar KW, Gan SH, et al. Tuberculosis treatment effect on T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens. Eur Respir J 2010; 36: 355.
47. Lee SH, Lew WJ, Kim HJ, et al. Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak. Respir Med 2010; 104: 448.
48. Lee SW, Lee CT, Yim JJ. Serial interferon-gamma release assays during treatment of active tuberculosis in young adults. BMC Infect Dis 2010; 10: 300.
49. Park JS, Lee JS, Kim MY, et al. Monthly follow-ups of interferon-gamma release assays among healthcare workers in contact with TB patients. Chest 2012; 142: 1461.
50. Soysal A, Toprak D, Koc M, et al. Diagnosing latent tuberculosis infection in haemodialysis patients: T-cell based assay (T-SPOT.TB) or tuberculin skin test? Nephrol Dial Transplant 2012; 27: 1645.